These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11943392)

  • 1. In vitro evaluation of a system for pH-controlled peroral delivery of metformin.
    Di Colo G; Falchi S; Zambito Y
    J Control Release; 2002 Apr; 80(1-3):119-28. PubMed ID: 11943392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A site-specific controlled-release system for metformin.
    Di Colo G; Zambito Y; Baggiani A; Carelli V; Serafini MF
    J Pharm Pharmacol; 2005 May; 57(5):565-71. PubMed ID: 15901345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
    Corti G; Cirri M; Maestrelli F; Mennini N; Mura P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):303-9. PubMed ID: 17616379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyoxyethylene-poly(methacrylic acid-co-methyl methacrylate) compounds for site-specific peroral delivery.
    Carelli V; Di Colo G; Nannipieri E; Poli B; Serafini MF
    Int J Pharm; 2000 Jul; 202(1-2):103-12. PubMed ID: 10915932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic drug--enterosoluble polymer coevaporates: development of oral controlled release systems.
    Govindarajan R; Nagarsenker MS
    Drug Dev Ind Pharm; 2004 Sep; 30(8):847-57. PubMed ID: 15521330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon.
    Zambito Y; Baggiani A; Carelli V; Serafini MF; Di Colo G
    J Control Release; 2005 Feb; 102(3):669-77. PubMed ID: 15681088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.
    Razavi M; Karimian H; Yeong CH; Sarji SA; Chung LY; Nyamathulla S; Noordin MI
    Drug Des Devel Ther; 2015; 9():3125-39. PubMed ID: 26124637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of colon targeted drug delivery systems for albendazole using kneading, extrusion and compaction technology.
    Emeje M; Nwabunike P; Isimi Y; Kunle O; Ofoefule S
    Yao Xue Xue Bao; 2009 Oct; 44(10):1152-8. PubMed ID: 20055141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight.
    Ramkissoon-Ganorkar C; Liu F; Baudys M; Kim SW
    J Control Release; 1999 Jun; 59(3):287-98. PubMed ID: 10332061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
    Al-Zoubi NM; AlKhatib HS; Obeidat WM
    Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and in vitro evaluation of formulations with pH and transit time controlled sigmoidal release profile for colon-specific delivery.
    Ali Asghar LF; Azeemuddin M; Jain V; Chandran S
    Drug Deliv; 2009 Aug; 16(6):295-303. PubMed ID: 19606943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
    Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Evaluation of Hydrophilic Matrix System Containing Polyethylene Oxides for the Zero-Order Controlled Delivery of Water-Insoluble Drugs.
    Wang L; Chen K; Wen H; Ouyang D; Li X; Gao Y; Pan W; Yang X
    AAPS PharmSciTech; 2017 Jan; 18(1):82-92. PubMed ID: 26883263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: preparation and in vitro/in vivo evaluation.
    He W; Li Y; Zhang R; Wu Z; Yin L
    Int J Pharm; 2014 Dec; 476(1-2):223-31. PubMed ID: 25283698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
    Momoh MA; Kenechukwu FC; Attama AA
    Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.
    Bandari S; Eaga CM; Thadishetty A; Yamsani MR
    Acta Pharm; 2010 Mar; 60(1):89-97. PubMed ID: 20228043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
    Asghar LF; Chandran S
    Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.